Test lens
DeviceMultifocal Toric Contact Lenses manufactured in Senofilcon A (C3) material with UV/HEV filter
NCT Number: NCT05433571
The study is a bilateral, single-masked, single-visit, non-dispensing 2x2 crossover study to confirm a finalized design of a prototype contact lens. There will be eight study lens types, however, each subject will only be randomized to receive two study lens types.
Looking for future studies?
Notify Me40 year–70 year
All sexes
Interventional
Not applicable
Stam & Associates Eye Care, Jacksonville, Florida, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Potential subjects must satisfy all of the following criteria to be enrolled in the study:
Exclusion criteria
Potential subjects who meet any of the following criteria will be excluded from participating in the study:
Multifocal Toric Contact Lenses manufactured in Senofilcon A (C3) material with UV/HEV filter
Time frame: 15-minutes post lens insertion
Absolute rotation was assessed for each subject eye using a slit lamp, at 1-, 3-, 7-, 15- and 25-minutes after lens insertion. However, absolute rotation at 15-minutes was the primary endpoint. Acceptable absolute rotation was dichotomized into a binary response where Y=1 if absolute rotation was less than or equal to 10 degrees and Y=0 otherwise (absolute rotation greater than 10 degrees). The proportion of eyes with absolute rotation less than or equal to 10 degrees was report for each lens.
Johnson & Johnson Vision Care, Inc.
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07174596
Visual Acuity
Roswell, Georgia, United States
View Trial DetailsNCT07076160
Eye Diseases, Presbyopia
Jacksonville, Florida, United States
View Trial DetailsNCT06864858
Visual Acuity
Maitland, Florida, United States
View Trial DetailsNCT07443215
Visual Acuity
Jacksonville, Florida, United States
View Trial Details